79 related articles for article (PubMed ID: 15109285)
21. HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence.
Wamburu G; Masenga EJ; Moshi EZ; Schmid-Grendelmeier P; Kempf W; Orfanos CE
Eur J Dermatol; 2006; 16(6):677-82. PubMed ID: 17229611
[TBL] [Abstract][Full Text] [Related]
22. [A five year follow-up of an HHV-8 related lymphoma in an HIV-negative elderly patient].
Danese C; Angrisani L; Colotto M; Clarice A; Ferranti E
Clin Ter; 2004; 155(11-12):543-6. PubMed ID: 15861969
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
[TBL] [Abstract][Full Text] [Related]
24. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
[TBL] [Abstract][Full Text] [Related]
25. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
[TBL] [Abstract][Full Text] [Related]
26. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
27. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma of the recto sigmoid colon in a patient with HIV infection and a high CD4 count.
Acharya S; Ross JD
Int J STD AIDS; 2007 Jul; 18(7):499-500. PubMed ID: 17623511
[TBL] [Abstract][Full Text] [Related]
29. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of Kaposi's sarcoma-associated herpesvirus viremia during hematopoietic stem cell mobilization with filgrastim.
Neid JM; Schooley RT; Campbell TB
Am J Hematol; 2004 Dec; 77(4):410-2. PubMed ID: 15551282
[TBL] [Abstract][Full Text] [Related]
32. Comparative prevalence of plasma human herpesvirus 8 DNA in sexual contact and intravenous injection routes of HIV transmission.
Lin CW; Chang CP; Wu FY; Liu CL
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):428-30. PubMed ID: 18248434
[TBL] [Abstract][Full Text] [Related]
33. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
34. Effusion and solid lymphomas have distinctive gene and protein expression profiles in an animal model of primary effusion lymphoma.
Yanagisawa Y; Sato Y; Asahi-Ozaki Y; Ito E; Honma R; Imai J; Kanno T; Kano M; Akiyama H; Sata T; Shinkai-Ouchi F; Yamakawa Y; Watanabe S; Katano H
J Pathol; 2006 Aug; 209(4):464-73. PubMed ID: 16741895
[TBL] [Abstract][Full Text] [Related]
35. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
36. Control of human herpes virus type 8-associated diseases by NK cells.
Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
[TBL] [Abstract][Full Text] [Related]
37. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved.
Castillo JJ; Shum H; Lahijani M; Winer ES; Butera JN
Leuk Lymphoma; 2012 Dec; 53(12):2378-82. PubMed ID: 22591071
[TBL] [Abstract][Full Text] [Related]
38. Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association.
Mwakigonja AR; Pak F; Pyakurel P; Mosha IJ; Urassa WK; Kaaya EE; Biberfeld P
Oncol Rep; 2007 Jun; 17(6):1291-9. PubMed ID: 17487381
[TBL] [Abstract][Full Text] [Related]
39. Intracardiac extra-cavitary primary effusion lymphoma in an HIV-infected patient.
Henao-Martínez AF; Gray JM; González-Fontal GR; Reves R
Int J STD AIDS; 2013 Jan; 24(1):78-9. PubMed ID: 24400343
[No Abstract] [Full Text] [Related]
40. Kaposi's sarcoma of the gastrointestinal tract: report of two cases and review of the literature.
Kahl P; Buettner R; Friedrichs N; Merkelbach-Bruse S; Wenzel J; Carl Heukamp L
Pathol Res Pract; 2007; 203(4):227-31. PubMed ID: 17379429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
